¿Existe dificultad para mantener los objetivos de hemoglobina en pacientes prediálisis tratados con agentes estimulantes de la eritropoyesis?
Is there a difficulty in maintaining haemoglobin target levels in pre-dialysis patients treated with erythropoiesis-stimulating agents?
Leído
14709
Vecesse ha leído el artículo
3331
Total PDF
11378
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 76 | 11 | 87 |
| 2025 5 | 80 | 35 | 115 |
| 2025 4 | 78 | 27 | 105 |
| 2025 3 | 117 | 53 | 170 |
| 2025 2 | 85 | 32 | 117 |
| 2025 1 | 82 | 42 | 124 |
| 2024 12 | 54 | 35 | 89 |
| 2024 11 | 55 | 49 | 104 |
| 2024 10 | 57 | 38 | 95 |
| 2024 9 | 77 | 29 | 106 |
| 2024 8 | 60 | 58 | 118 |
| 2024 7 | 70 | 22 | 92 |
| 2024 6 | 95 | 43 | 138 |
| 2024 5 | 93 | 35 | 128 |
| 2024 4 | 89 | 48 | 137 |
| 2024 3 | 69 | 31 | 100 |
| 2024 2 | 60 | 37 | 97 |
| 2024 1 | 58 | 20 | 78 |
| 2023 12 | 54 | 34 | 88 |
| 2023 11 | 62 | 49 | 111 |
| 2023 10 | 69 | 36 | 105 |
| 2023 9 | 48 | 37 | 85 |
| 2023 8 | 54 | 19 | 73 |
| 2023 7 | 59 | 39 | 98 |
| 2023 6 | 84 | 20 | 104 |
| 2023 5 | 72 | 62 | 134 |
| 2023 4 | 53 | 37 | 90 |
| 2023 3 | 90 | 26 | 116 |
| 2023 2 | 51 | 32 | 83 |
| 2022 1 | 53 | 31 | 84 |
| 2022 12 | 82 | 39 | 121 |
| 2022 11 | 72 | 45 | 117 |
| 2022 10 | 83 | 69 | 152 |
| 2022 9 | 61 | 53 | 114 |
| 2022 8 | 65 | 48 | 113 |
| 2022 7 | 48 | 65 | 113 |
| 2022 6 | 35 | 45 | 80 |
| 2022 5 | 40 | 50 | 90 |
| 2022 4 | 71 | 63 | 134 |
| 2022 3 | 49 | 63 | 112 |
| 2022 2 | 85 | 51 | 136 |
| 2021 1 | 51 | 50 | 101 |
| 2021 12 | 51 | 56 | 107 |
| 2021 11 | 68 | 34 | 102 |
| 2021 10 | 53 | 50 | 103 |
| 2021 9 | 64 | 52 | 116 |
| 2021 8 | 57 | 47 | 104 |
| 2021 7 | 30 | 46 | 76 |
| 2021 6 | 59 | 37 | 96 |
| 2021 5 | 65 | 57 | 122 |
| 2021 4 | 143 | 103 | 246 |
| 2021 3 | 108 | 44 | 152 |
| 2021 2 | 75 | 34 | 109 |
| 2020 1 | 71 | 31 | 102 |
| 2020 12 | 52 | 24 | 76 |
| 2020 11 | 53 | 28 | 81 |
| 2020 10 | 68 | 25 | 93 |
| 2020 9 | 66 | 24 | 90 |
| 2020 8 | 46 | 29 | 75 |
| 2020 7 | 46 | 18 | 64 |
| 2020 6 | 57 | 20 | 77 |
| 2020 5 | 58 | 26 | 84 |
| 2020 4 | 56 | 15 | 71 |
| 2020 3 | 51 | 18 | 69 |
| 2020 2 | 65 | 23 | 88 |
| 2020 1 | 93 | 34 | 127 |
| 2019 12 | 63 | 22 | 85 |
| 2019 11 | 72 | 18 | 90 |
| 2019 10 | 75 | 14 | 89 |
| 2019 9 | 64 | 38 | 102 |
| 2019 8 | 41 | 18 | 59 |
| 2019 7 | 41 | 19 | 60 |
| 2019 6 | 47 | 29 | 76 |
| 2019 5 | 34 | 19 | 53 |
| 2019 4 | 100 | 49 | 149 |
| 2019 3 | 73 | 31 | 104 |
| 2019 2 | 50 | 31 | 81 |
| 2019 1 | 64 | 23 | 87 |
| 2018 12 | 110 | 57 | 167 |
| 2018 11 | 148 | 19 | 167 |
| 2018 10 | 131 | 25 | 156 |
| 2018 9 | 107 | 17 | 124 |
| 2018 8 | 102 | 24 | 126 |
| 2018 7 | 98 | 23 | 121 |
| 2018 6 | 99 | 21 | 120 |
| 2018 5 | 99 | 24 | 123 |
| 2018 4 | 121 | 12 | 133 |
| 2018 3 | 126 | 9 | 135 |
| 2018 2 | 93 | 12 | 105 |
| 2018 1 | 80 | 13 | 93 |
| 2017 12 | 74 | 12 | 86 |
| 2017 11 | 70 | 19 | 89 |
| 2017 10 | 82 | 12 | 94 |
| 2017 9 | 71 | 16 | 87 |
| 2017 8 | 62 | 8 | 70 |
| 2017 7 | 69 | 15 | 84 |
| 2017 6 | 84 | 15 | 99 |
| 2017 5 | 78 | 11 | 89 |
| 2017 4 | 76 | 11 | 87 |
| 2017 3 | 87 | 10 | 97 |
| 2017 2 | 73 | 7 | 80 |
| 2016 1 | 29 | 3 | 32 |
| 2016 12 | 101 | 7 | 108 |
| 2016 11 | 147 | 9 | 156 |
| 2016 10 | 190 | 17 | 207 |
| 2016 9 | 211 | 2 | 213 |
| 2016 8 | 262 | 2 | 264 |
| 2016 7 | 253 | 5 | 258 |
| 2016 6 | 158 | 0 | 158 |
| 2016 5 | 162 | 0 | 162 |
| 2016 4 | 173 | 0 | 173 |
| 2016 3 | 148 | 0 | 148 |
| 2016 2 | 165 | 0 | 165 |
| 2015 1 | 171 | 0 | 171 |
| 2015 12 | 152 | 0 | 152 |
| 2015 11 | 146 | 0 | 146 |
| 2015 10 | 144 | 0 | 144 |
| 2015 9 | 140 | 0 | 140 |
| 2015 8 | 108 | 0 | 108 |
| 2015 7 | 126 | 0 | 126 |
| 2015 6 | 85 | 0 | 85 |
| 2015 5 | 136 | 0 | 136 |
| 2015 4 | 40 | 0 | 40 |
| 2015 2 | 866 | 0 | 866 |
Mostrar todo
